Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer's Disease Model Mice.
Adenylate Kinase
/ metabolism
Administration, Oral
Alzheimer Disease
/ enzymology
Amyloid beta-Peptides
/ metabolism
Animals
Brain
/ drug effects
Cognition
/ drug effects
Disease Models, Animal
Enzyme Activation
/ drug effects
Inflammation
/ pathology
Long-Term Potentiation
/ drug effects
Mice, Inbred C57BL
Mice, Transgenic
Models, Biological
Neuronal Plasticity
/ drug effects
Receptors, Adrenergic, alpha-1
/ metabolism
Recognition, Psychology
/ drug effects
Spatial Memory
ortho-Aminobenzoates
/ administration & dosage
Alzheimer’s disease
Amyloid-β
Avn-C
LTP
Memory
Mouse model
Oats
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
23
04
2019
accepted:
10
07
2019
pubmed:
25
7
2019
medline:
8
10
2020
entrez:
24
7
2019
Statut:
ppublish
Résumé
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline and dementia with no effective treatment. Here, we investigated a novel compound from oats named avenanthramide-C (Avn-C), on AD-related memory impairment and behavioral deficits in transgenic mouse models. Acute hippocampal slices of wild-type or AD transgenic mice were treated with Avn-C in the presence or absence of oligomeric Aβ
Identifiants
pubmed: 31332763
doi: 10.1007/s12035-019-01707-5
pii: 10.1007/s12035-019-01707-5
doi:
Substances chimiques
Amyloid beta-Peptides
0
Receptors, Adrenergic, alpha-1
0
ortho-Aminobenzoates
0
avenanthramide-2C
5FRF61BOYU
Adenylate Kinase
EC 2.7.4.3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
315-330Subventions
Organisme : National Research Foundation of Korea
ID : NRF-2014M3C1A3053029
Organisme : National Research Foundation of Korea
ID : NRF-2016R1A2B4008316
Organisme : National Research Foundation of Korea
ID : 2016R1D1A3B03931710
Organisme : Cooperative Research Program for Agriculture Science & Technology Development
ID : PJ010508042014, PJ01255102 and PJ01255104
Références
J Agric Food Chem. 2011 Jun 22;59(12):6438-43
pubmed: 21417395
J Comp Neurol. 2006 Jul 10;497(2):209-22
pubmed: 16705673
Mol Psychiatry. 2017 Mar;22(3):407-416
pubmed: 27001618
J Biol Chem. 2010 May 14;285(20):15346-55
pubmed: 20233722
Mol Neurobiol. 2014 Oct;50(2):534-44
pubmed: 24567119
Physiol Behav. 2001 Aug;73(5):705-17
pubmed: 11566205
J Immunol. 2015 Jan 15;194(2):584-94
pubmed: 25512602
J Neuropathol Exp Neurol. 1995 Mar;54(2):276-81
pubmed: 7876895
J Recept Signal Transduct Res. 2017 Apr;37(2):124-132
pubmed: 27277698
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5161-6
pubmed: 16549764
Biomed Res Int. 2014;2014:692061
pubmed: 25025067
Atherosclerosis. 2006 Jun;186(2):260-6
pubmed: 16139284
J Am Osteopath Assoc. 2005 Mar;105(3):145-58
pubmed: 15863734
Nutr J. 2014 Mar 19;13:21
pubmed: 24645793
Brain Pathol. 2009 Jul;19(3):392-8
pubmed: 18637012
Ann N Y Acad Sci. 1996 Jan 17;777:213-20
pubmed: 8624086
Exp Gerontol. 2007 Mar;42(3):233-40
pubmed: 17085001
Pharmacol Biochem Behav. 2015 Feb 17;132:33-41
pubmed: 25697476
J Biol Chem. 2012 Nov 23;287(48):40441-7
pubmed: 23024365
Biol Psychiatry. 2010 Nov 15;68(10):930-41
pubmed: 20692646
Pathol Res Pract. 2017 Jan;213(1):13-22
pubmed: 27916297
Sci Rep. 2015 Jun 09;5:10934
pubmed: 26055072
Synapse. 1999 Mar 1;31(3):196-202
pubmed: 10029237
J Neural Transm (Vienna). 2001;108(4):445-50
pubmed: 11475011
N Engl J Med. 2010 Jan 28;362(4):329-44
pubmed: 20107219
EPMA J. 2013 Feb 18;4(1):5
pubmed: 23418936
Acta Neuropathol. 1995;89(6):544-51
pubmed: 7676810
Am J Geriatr Psychiatry. 2009 Sep;17(9):744-51
pubmed: 19700947
Food Chem. 2014 Oct 1;160:338-45
pubmed: 24799247
Mol Pharmacol. 2011 Oct;80(4):747-58
pubmed: 21791575
J Nutr. 2007 Jun;137(6):1375-82
pubmed: 17513394
Br J Nutr. 2016 Feb 14;115(3):449-65
pubmed: 26652155
Neurol Res. 2018 Apr;40(4):268-276
pubmed: 29458298
Nat Neurosci. 2005 Aug;8(8):1051-8
pubmed: 16025111
Brain Pathol. 1998 Jan;8(1):65-72
pubmed: 9458167
Nat Neurosci. 2010 Jul;13(7):812-8
pubmed: 20581818
Mol Cell Biol. 2007 Jun;27(12):4317-27
pubmed: 17420279
Expert Opin Emerg Drugs. 2012 Mar 23;:null
pubmed: 22439907
Nat Neurosci. 2011 May;14(5):545-7
pubmed: 21441921
Diabetes. 2006 Mar;55(3):682-90
pubmed: 16505231
Biochim Biophys Acta. 2015 Jun;1852(6):1202-8
pubmed: 25315300
J Neurosci. 2006 Oct 4;26(40):10129-40
pubmed: 17021169
J Biol Chem. 2003 Aug 1;278(31):28434-42
pubmed: 12764152
CNS Neurol Disord Drug Targets. 2010 Apr;9(2):132-9
pubmed: 20205647
Free Radic Biol Med. 2008 Feb 1;44(3):415-29
pubmed: 18062932
Cell. 2010 May 28;141(5):859-71
pubmed: 20510932
Science. 1996 Oct 4;274(5284):99-102
pubmed: 8810256
Nat Neurosci. 2011 Jan;14(1):69-76
pubmed: 21151119
Sci Rep. 2017 Sep 11;7(1):11118
pubmed: 28894284
J Biol Chem. 2010 Mar 19;285(12):9100-13
pubmed: 20080969
Front Mol Neurosci. 2015 Dec 18;8:77
pubmed: 26733801
Expert Opin Drug Saf. 2004 Sep;3(5):425-40
pubmed: 15335298
Mol Neurobiol. 2015 Apr;51(2):466-79
pubmed: 24826916
Cell. 2010 Aug 6;142(3):387-97
pubmed: 20655099
Diabetes. 2006 Aug;55(8):2180-91
pubmed: 16873680
J Alzheimers Dis. 2014;42(4):1209-20
pubmed: 25024312
Cell Metab. 2005 Jan;1(1):15-25
pubmed: 16054041
Neuron. 2007 Feb 1;53(3):337-51
pubmed: 17270732
Eur J Neurosci. 2005 Dec;22(11):2827-32
pubmed: 16324117
J Mol Med (Berl). 2011 Jul;89(7):667-76
pubmed: 21431325
Sci Rep. 2017 Mar 22;7:44989
pubmed: 28327638
Naunyn Schmiedebergs Arch Pharmacol. 1985 Jun;329(4):404-13
pubmed: 2993928
Peptides. 2006 Nov;27(11):2738-49
pubmed: 16914228
Glia. 1993 Jan;7(1):75-83
pubmed: 8423065
Nat Neurosci. 1999 Mar;2(3):271-6
pubmed: 10195221
Brain. 2008 Mar;131(Pt 3):651-64
pubmed: 18292081
Neuron. 2006 Dec 7;52(5):831-43
pubmed: 17145504